Blueleaf

Belkins
At Blueleaf, the combined company formed by NHG and Clinicare Supplies, we empower the success of care homes around the world through the passion of our people and smart solutions. Blueleaf provides one of the most comprehensive ranges of products and services - from consumables and equipment, to furniture and interior design.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

VIR BIOTECHNOLOGY AND WUXI BIOLOGICS ANNOUNCE COLLABORATION FOR GLOBAL DEVELOPMENT OF ANTIBODIES TO TREAT COVID-19

BioSpace | February 25, 2020

news image

Vir Biotechnology, Inc. and WuXi Biologics today announced a development and manufacturing collaboration to advance and produce human monoclonal antibodies for the potential treatment of COVID-19 (Coronavirus Disease 2019), a disease caused by SARS-CoV-2. Under the terms of the agreement, the companies will work together on the clinical development, manufacturing, and commercialization of Vir’s proprietary antibodies. WuXi Biologics will conduct cell-line development, process and for...

Read More

TRANSPOSABLE ELEMENTS ROLE IN GENETIC EXPRESSION COULD IMPROVE STUDY OF NEURODEGENERATIVE DISEASE

GEN | April 15, 2020

news image

Researchers in Michigan published a study “Transposable elements contribute to cell and species-specific chromatin looping and gene regulation in mammalian genomes” in Nature Communications that shows that transposable elements play an important role in regulating genetic expression with implications to advance the understanding of genetic evolution, with potential applications in neurodegenerative diseases. Transposable elements move around the cell, and, unlike previously thought, ...

Read More

FUJIFILM DIOSYNTH BIOTECHNOLOGIES ENTERS STRATEGIC PARTNERSHIP WITH OXGENE™ TO ADDRESS SUPPLY BOTTLENECKS IN GENE THERAPY DEVELOPMENT & MANUFACTURING

FUJIFILM Diosynth Biotechnologies | April 23, 2020

news image

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and production of their biologics, vaccines and gene therapies, announced a strategic partnership with OXGENE™, an industry leader in the design and development of gene therapy technologies. This partnership will enable FDB to deliver gene therapy products to clients with an approximate 25% le...

Read More

MEDICAL

AMBAGON THERAPEUTICS LAUNCHES WITH $85 MILLION SERIES A TO ADVANCE PIONEERING MOLECULAR GLUE PLATFORM AND PROGRESS PIPELINE

Ambagon Therapeutics | January 07, 2022

news image

Ambagon Therapeutics, a biotechnology company unlocking intrinsically disordered proteins and other difficult-to-target protein classes, announced an $85 million Series A to augment its drug discovery platform and to advance its pipeline of molecular glues. The financing was led by Nextech Invest. Ambagon was previously seeded by RA Capital Management, Droia Ventures, Inkef Capital, AbbVie Ventures, MRL Ventures Fund, and Mission BioCapital. Investors from the seed round joined th...

Read More
news image

VIR BIOTECHNOLOGY AND WUXI BIOLOGICS ANNOUNCE COLLABORATION FOR GLOBAL DEVELOPMENT OF ANTIBODIES TO TREAT COVID-19

BioSpace | February 25, 2020

Vir Biotechnology, Inc. and WuXi Biologics today announced a development and manufacturing collaboration to advance and produce human monoclonal antibodies for the potential treatment of COVID-19 (Coronavirus Disease 2019), a disease caused by SARS-CoV-2. Under the terms of the agreement, the companies will work together on the clinical development, manufacturing, and commercialization of Vir’s proprietary antibodies. WuXi Biologics will conduct cell-line development, process and for...

Read More
news image

TRANSPOSABLE ELEMENTS ROLE IN GENETIC EXPRESSION COULD IMPROVE STUDY OF NEURODEGENERATIVE DISEASE

GEN | April 15, 2020

Researchers in Michigan published a study “Transposable elements contribute to cell and species-specific chromatin looping and gene regulation in mammalian genomes” in Nature Communications that shows that transposable elements play an important role in regulating genetic expression with implications to advance the understanding of genetic evolution, with potential applications in neurodegenerative diseases. Transposable elements move around the cell, and, unlike previously thought, ...

Read More
news image

FUJIFILM DIOSYNTH BIOTECHNOLOGIES ENTERS STRATEGIC PARTNERSHIP WITH OXGENE™ TO ADDRESS SUPPLY BOTTLENECKS IN GENE THERAPY DEVELOPMENT & MANUFACTURING

FUJIFILM Diosynth Biotechnologies | April 23, 2020

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and production of their biologics, vaccines and gene therapies, announced a strategic partnership with OXGENE™, an industry leader in the design and development of gene therapy technologies. This partnership will enable FDB to deliver gene therapy products to clients with an approximate 25% le...

Read More
news image

MEDICAL

AMBAGON THERAPEUTICS LAUNCHES WITH $85 MILLION SERIES A TO ADVANCE PIONEERING MOLECULAR GLUE PLATFORM AND PROGRESS PIPELINE

Ambagon Therapeutics | January 07, 2022

Ambagon Therapeutics, a biotechnology company unlocking intrinsically disordered proteins and other difficult-to-target protein classes, announced an $85 million Series A to augment its drug discovery platform and to advance its pipeline of molecular glues. The financing was led by Nextech Invest. Ambagon was previously seeded by RA Capital Management, Droia Ventures, Inkef Capital, AbbVie Ventures, MRL Ventures Fund, and Mission BioCapital. Investors from the seed round joined th...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us